Cite
Relevance of kappa free light chains index in patients with aquaporin-4 or myelin-oligodendrocyte-glycoprotein antibodies.
MLA
Deschamps, Romain, et al. “Relevance of Kappa Free Light Chains Index in Patients with Aquaporin-4 or Myelin-Oligodendrocyte-Glycoprotein Antibodies.” European Journal of Neurology, vol. 30, no. 9, Sept. 2023, pp. 2865–69. EBSCOhost, https://doi.org/10.1111/ene.15897.
APA
Deschamps, R., Shor, N., Papeix, C., Boudot de la Motte, M., Bensa, C., Marignier, R., Lecler, A., Vignal-Clermont, C., Ghillani, P., Gazzano, M., Maillart, E., & Sterlin, D. (2023). Relevance of kappa free light chains index in patients with aquaporin-4 or myelin-oligodendrocyte-glycoprotein antibodies. European Journal of Neurology, 30(9), 2865–2869. https://doi.org/10.1111/ene.15897
Chicago
Deschamps, Romain, Natalia Shor, Caroline Papeix, Marine Boudot de la Motte, Caroline Bensa, Romain Marignier, Augustin Lecler, et al. 2023. “Relevance of Kappa Free Light Chains Index in Patients with Aquaporin-4 or Myelin-Oligodendrocyte-Glycoprotein Antibodies.” European Journal of Neurology 30 (9): 2865–69. doi:10.1111/ene.15897.